Health & Medicine

WHO renews commitment to a leprosy-free world, spotlighting partnership and progress ahead of World Leprosy Day

26 sec read5 views0 listens

The World Health Organization (WHO) renewed its commitment to eliminating leprosy and extended a Memorandum of Understanding with Novartis for five more years, ensuring continued free access to multidrug therapy and clofazimine globally. This partnership highlights the importance of global collaboration in combating ancient diseases and reducing stigma associated with leprosy, emphasizing the need for sustained efforts from all stakeholders.

Read the full article at WHO News

Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.

You Might Like

Tech & Gadgets10 hours ago25 sec read

How Toronto is using Clariti's AI to speed up building permit approvals

Toronto has launched a one-year pilot program with Clariti's CivCheck AI software to expedite the city's building permit approval process. This initiative aims to reduce delays caused by incomplete applications, which can add significant costs for de...

Ali Nemati

Biotech & Pharma13 hours ago28 sec read

CAR T-Cell Therapy Puts Severe Rheumatoid Arthritis Into Remission in First Clinical Trial

A Phase 1 clinical trial at Charité—Universitätsmedizin Berlin has shown that CAR T-cell therapy significantly reduced disease activity in six patients with severe, treatment-refractory rheumatoid arthritis (RA), with three achieving sustained remiss...

Ali Nemati

Fitness & Wellness13 hours ago29 sec read

Google Health gets better workout logging, improved maps, and Health Connect fixes

Google Health 5.07 introduces enhanced features for workout logging, improved maps for various running conditions, and fixes for Health Connect stability issues affecting Android users. These updates address user feedback and improve navigation and f...

Ali Nemati